Regrettably, the European Medicines Agency (EMA) is being turned into a mere provider of services to the pharmaceutical industry. Other strategies for funding that would help drug regulatory agencies to be more independent do exist. They should be carefully considered.
Category: Campaigns
Comments on Quality Review of Documents (QRD): revision of the product information – Draft
Submission of comments on 'Quality Review of Documents (QRD) human product information annotated template: revision of the product information - Draft' (EMA/468498/2012)
Access to EU Institutions’ documents is essential to advance trasparency and to serve public health
EU Parliament says no and no again to EMA: Independent groups echo decision
ISDB General Assembly Meeting – 2012
March 25 - 28, 2012
Vancouver, BC, Canada
Vancouver, BC, Canada
See Programme (25 KB)
More information available on: http://ti.ubc.ca/ISDB-2012